- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
Mergers and acquisitions (M&A) played an important role in helping oil and gas companies survive through one of the most tumultuous times over the last five years, as oil price continues to be volatile ever since falling from $100 a barrel in 2014, according to GlobalData, a leading data and analytics company. The company’s report: […]
Development of drugs with novel MOAs marks a shift in glaucoma corporate strategy
With no new classes of drugs having been developed for the treatment of glaucoma in the last twenty years, the focus of pharmaceutical companies has begun to shift towards the development of glaucoma drugs with novel mechanisms of action (MOAs), and this trend is expected to continue to 2026. The launch of 11 new therapies […]
China and US lead global ethylene capacity additions by 2026, says GlobalData
Global ethylene capacity is expected to experience considerable growth between 2017 and 2026, increasing from 180 million tons per annum (mtpa) in 2017 to more than 270 mtpa in 2026, led by China and the US, according to GlobalData, a leading data and analytics company. The company’s report: ‘Q4 2018 Global Ethylene Capacity and Capital […]
Romania will be the capacity growth engine for gas processing industry in Europe to 2022, says GlobalData
Romania will drive most of the growth in the gas processing industry in Europe between 2018 and 2022, contributing around 94% of Europe’s planned gas processing capacity, according to GlobalData, a leading data and analytics company. The company’s report: ‘Gas Processing Industry Outlook in Europe to 2022 – Capacity and Capital Expenditure Forecasts with Details […]
Significant number of drugs will launch for the treatment of age-related macular degeneration by 2026
The age-related macular degeneration (AMD) market has been dominated by big pharma companies and their pipeline candidates are ensuring a share of this lucrative market, in spite of patent expiries of their highly-priced products, according to GlobalData, a leading data and analytics company. Roche and Novartis’ Lucentis (ranibizumab) was the first anti-VEGF monoclonal antibody designed […]
Traditional wealth managers set to lose market share to robo-advisors, says GlobalData
The robo-advisory market is increasing in competition globally, with more start-ups entering the wealth management industry year by year, says GlobalData, a leading data and analytics company. Sergel Woldemicheal, Wealth Management Analyst at GlobalData comments: “In previous years, traditional wealth managers across the globe had a widespread level of agreement that robo-advice would seize market […]
Russia will drive underground gas storage industry growth in Former Soviet Union, says GlobalData
Russia is expected to be the major contributor to the growth of the underground working gas storage capacity in the Former Soviet Union (FSU) between 2018 and 2022, accounting for around 92% of the total region’s growth, according to GlobalData, a leading data and analytics company. The company’s report: ‘Underground Gas Storage Industry Outlook in […]
Despite drop in share, APAC will lead global solar PV market volume through 2022, says GlobalData
Despite a drop in its share, the Asia-Pacific (APAC) region, with its large population base and strong requirement for electricity generation capacity, will continue to influence the global solar PV module market over the forecast period 2018-2022, according to GlobalData, a leading data and analytics company. The company’s latest report, ‘Solar PV Module, Update 2018’, […]
Eli Lilly’s acquisition of Loxo Oncology will result in quick return of investment
Eli Lilly’s acquisition of Loxo Oncology marks the second multibillion-dollar deal in 2019 following the recent BMS and Celgene merger. Volkan Gunduz, PhD, Senior Oncology and Hematology Analyst at GlobalData, a leading data and analytics company, offers his view on the acquisition: “Eli Lilly’s choice of Loxo is highly strategic due to Loxo’s unique oncology […]
Cybersecurity concerns will increase in UK wealth management industry in 2019, says GlobalData
In the UK, clients of wealth managers are less apprehensive about data breaches than the majority of their global counterparts. However, examples of data breaches closer to home will influence consumer awareness around the topic and increase concerns, says GlobalData, a leading data and analytics company. GlobalData’s 2018 survey of wealth managers found that, globally, […]
Russia leads with highest capacity additions in gas processing industry in Former Soviet Union to 2022, says GlobalData
Russia will account for 42% of the total capacity additions in the gas processing industry in the Former Soviet Union between 2018 and 2022, according to GlobalData, a leading data and analytics company. The company’s report: ‘Gas Processing Industry Outlook in Former Soviet Union to 2022 – Capacity and Capital Expenditure Forecasts with Details of […]
AbbVie and J&J dominate clinical trial development in psoriatic arthritis
AbbVie and Johnson & Johnson (J&J) are responsible for 47 of the 121 industry sponsored clinical trials in the psoriatic arthritis space, according to GlobalData, a leading data and analytics company. The company’s latest report: ‘Psoriatic Arthritis: Competitive Landscape to 2026’ found that industry sponsors are responsible for over 70% of psoriatic arthritis clinical trials, […]
APAC will lead global wind gearbox and direct drive equipment markets over next four years, says GlobalData
Asia-Pacific (APAC) is expected to lead the global wind gearbox and direct drive equipment markets with a share of 46% and 53.5%, respectively over the forecast period (2018–2022), says GlobalData, a leading data and analytics company. The company’s latest report, ‘Wind Gearbox and Direct Drive, Update 2018’, reveals that the global trends of wind power […]
Growth of cloud computing space offers immense opportunity for pharma in 2019, says GlobalData
The total healthcare cloud computing market size is forecast to be almost $35bn in 2022, growing at a Compound Annual Growth Rate (CAGR) of 21.7% between 2018 and 2022, says GlobalData, a leading data and analytics company. The company’s latest report ‘Cloud Computing in Healthcare – Thematic Research’ found that in recent years, investing in […]
Bristol-Myers Squibb’s acquisition of Celgene could position the company amongst top five most profitable Pharma giants
Following Bristol-Myers Squibb’s (BMS) announcement on 3 January 2019 that it will acquire Celgene in a cash and stock deal with an equity value of approximately $74bn, Edit Kovalcsik, Managing Pharma Analyst at GlobalData, a leading data and analytics company, offers her view on this significant merger: “Amidst the inevitable transformation of the pharmaceutical industry, […]
Drug pricing and reimbursement concerns will remain the leading impediment to industry growth in 2019
In 2019, drug pricing pressure from regulators, patients, politicians and payers will remain and aggressive negotiation tactics to drive down drug prices are expected, says GlobalData, a leading data and analytics company. The company’s latest annual outlook report, ‘The State of the Biopharmaceutical Industry – 2019’, reveals that 51% of global industry respondents believe that […]
Next-generation sequencing will shape the companion diagnostics market in the next five years
The global companion diagnostics (CDx) market will be shaped by next-generation sequencing (NGS) technologies over the next five years, according to GlobalData, a leading data and analytics company. The company’s latest report: ‘Biomarkers and Companion Diagnostics in Oncology’ states that one of the most important drivers of the market for CDx will be the increased […]
Merck and AstraZeneca’s Lynparza well positioned to sustain dominance of PARP inhibitor market
Following the news on 20 December 2018 that Merck and AstraZeneca’s Lynparza has been approved by the FDA for first-line maintenance therapy of BRCA-mutated ovarian cancer, Paul Jeng, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on the PARP inhibitor competitive landscape: “Lynparza is now the first PARP inhibitor to […]
R&D returns fall to lowest level in nine years, says Deloitte and GlobalData
Projected returns on investment in research and development (R&D) for the top 12 biopharmaceutical companies have fallen to 1.9 per cent, according to a study by Deloitte’s Centre for Health Solutions leveraging revenue forecasts and industry benchmarks generated by GlobalData, a leading data and analytics company. The study entitled, ‘Unlocking R&D productivity: Measuring the return […]
Drug development in neuroimmunology to witness strong growth in the 8MM
Drug development in neuroimmunology is expected to witness strong growth in the eight major markets (8MM*), primarily driven by deeper understanding of the underlying pathology of the various diseases, advancements in neurogenetics, and most importantly the potential of the field to develop drugs that offer targeted therapy mechanisms, according to GlobalData, a leading data and […]